|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Adial Pharmaceuticals, Inc. (ADIL) |
|
|
$0.24 0.00 (0.00%) as of 4:30 Fri 8/4
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
6,560,000 |
| Market
Cap: |
1.55(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.2023 - $0.385 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile ADial Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of therapeutics for the treatment or prevention of addiction and related disorders. Co.'s investigational new drug product, AD04, is being developed as a therapeutic agent for the treatment of alcohol use disorder. Co. has a license from the University of Virginia Patent Foundation to commercialize its AD04. The active pharmaceutical agent in AD04, Co.'s investigational new drug product, is ondansetron, which is also the active ingredient in Zofran®, an approval for nausea and vomiting post-operatively and after chemotherapy or radiation treatment and is commercially available in generic form.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
700 |
700 |
| Total Buy Value |
$0 |
$0 |
$1,918 |
$1,918 |
| Total People Bought |
0 |
0 |
1 |
1 |
| Total Buy Transactions |
0 |
0 |
1 |
1 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-28 |
2023-12-26 |
2023-06-27 |
2022-06-27 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Johnson Bankole A. |
Chief Medical Officer |
• – • |
2019-10-02 |
4 |
A |
$0.00 |
$0 |
D/D |
3,187 |
351,055 |
|
- |
|
| Johnson Bankole A. |
Chief Medical Officer |
• – • |
2019-03-29 |
4 |
B |
$3.30 |
$114,801 |
D/D |
33,100 |
347,868 |
4.01 |
- |
|
| Johnson Bankole A. |
Chief Medical Officer |
• – • |
2019-03-28 |
4 |
B |
$3.15 |
$125,808 |
D/D |
40,000 |
314,768 |
4.01 |
- |
|
| Schuyler Kevin |
Director |
– • – |
2018-07-31 |
4/A |
A |
$0.00 |
$0 |
I/I |
144,200 |
144,200 |
|
- |
|
| Schuyler Kevin |
Director |
– • – |
2018-07-31 |
4/A |
B |
$0.00 |
$0 |
D/D |
90,000 |
312,990 |
2.31 |
- |
|
| Schuyler Kevin |
Director |
– • – |
2018-07-31 |
4/A |
A |
$0.00 |
$0 |
D/D |
89,600 |
222,990 |
|
- |
|
| Stilley William B. Iii |
Chief Executive Officer |
• • • |
2018-07-31 |
4 |
B |
$0.00 |
$0 |
D/D |
80,000 |
504,000 |
3.15 |
- |
|
| Stilley William B. Iii |
Chief Executive Officer |
• • • |
2018-07-31 |
4 |
A |
$0.00 |
$0 |
D/D |
52,227 |
424,629 |
|
- |
|
| Stilley William B. Iii |
Chief Executive Officer |
• • • |
2018-07-31 |
4 |
A |
$0.00 |
$0 |
D/D |
36,800 |
372,402 |
|
- |
|
| Newman James W. Jr. |
Director |
– • – |
2018-07-31 |
4 |
B |
$0.00 |
$0 |
D/D |
10,000 |
10,000 |
2.31 |
- |
|
| Newman James W. Jr. |
Director |
– • – |
2018-07-31 |
4 |
B |
$0.00 |
$0 |
I/I |
10,000 |
150,419 |
2.02 |
- |
|
| Newman James W. Jr. |
Director |
– • – |
2018-07-31 |
4 |
A |
$0.00 |
$0 |
I/I |
112,000 |
140,419 |
|
- |
|
| Newman James W. Jr. |
Director |
– • – |
2018-07-31 |
4 |
A |
$0.00 |
$0 |
I/I |
56,824 |
15,221 |
|
- |
|
| Goodman Tony |
Director |
– • – |
2018-07-31 |
4 |
B |
$0.00 |
$0 |
D/D |
7,000 |
8,755 |
2.31 |
- |
|
| Truluck Joseph |
Chief Financial Officer |
• – – |
2018-07-31 |
4 |
A |
$0.00 |
$0 |
D/D |
5,927 |
80,555 |
|
- |
|
| Gilliland Robertson H. |
Director |
– • – |
2018-07-31 |
4 |
B |
$0.00 |
$0 |
I/I |
14,000 |
109,424 |
2.02 |
- |
|
| Gilliland Robertson H. |
Director |
– • – |
2018-07-31 |
4 |
A |
$0.00 |
$0 |
I/I |
29,931 |
95,424 |
|
- |
|
| En Fidecomiso De Mi Vida 11/23/2010 Trust |
10% Owner |
– – • |
2018-07-31 |
4 |
A |
$0.00 |
$0 |
I/I |
40,382 |
313,750 |
|
- |
|
| En Fidecomiso De Mi Vida 11/23/2010 Trust |
10% Owner |
– – • |
2018-07-31 |
4 |
B |
$0.00 |
$0 |
D/D |
1,400 |
1,400 |
2.37 |
- |
|
| En Fidecomiso De Mi Vida 11/23/2010 Trust |
10% Owner |
– – • |
2018-07-31 |
4 |
A |
$0.00 |
$0 |
D/D |
17,600 |
273,368 |
|
- |
|
| En Fidecomiso De Mi Vida 11/23/2010 Trust |
10% Owner |
– – • |
2018-07-31 |
4 |
OE |
$0.44 |
$67,370 |
D/D |
153,114 |
255,768 |
|
- |
|
| Schuyler Kevin |
Director |
– • – |
2018-07-31 |
4 |
A |
$0.00 |
$0 |
I/I |
113,800 |
113,800 |
|
- |
|
| Schuyler Kevin |
Director |
– • – |
2018-07-31 |
4 |
B |
$0.00 |
$0 |
D/D |
90,000 |
343,390 |
2.31 |
- |
|
| Schuyler Kevin |
Director |
– • – |
2018-07-31 |
4 |
A |
$0.00 |
$0 |
D/D |
120,000 |
253,390 |
|
- |
|
| Schuyler Kevin |
Director |
– • – |
2018-07-31 |
4 |
A |
$0.00 |
$0 |
D/D |
82,461 |
133,390 |
|
- |
|
50 Records found
|
|
Page 2 of 2 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
